Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Di Ran

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Antioxidants (Basel, Switzerland)|May 25, 2024
Luteolin Alleviates Cadmium-Induced Kidney Injury by Inhibiting Oxidative DNA Damage and Repairing Autophagic Flux Blockade in ChickensKanglei Zhang, Jiahui Li, Wenxuan Dong, et al.
International Journal of Molecular Sciences|January 23, 2024
Cadmium Induces Kidney Iron Deficiency and Chronic Kidney Injury by Interfering with the Iron Metabolism in RatsKanglei Zhang, Mengfei Long, Wenxuan Dong, et al.
Toxicology|July 22, 2020
TGF-β-activated kinase 1 (TAK1) mediates cadmium-induced autophagy in osteoblasts via the AMPK / mTORC1 / ULK1 pathwayDi Ran, Yonggang Ma, Wei Liu, et al.
Toxicology|October 8, 2020
Cadmium induces apoptosis via generating reactive oxygen species to activate mitochondrial p53 pathway in primary rat osteoblastsJiaming Zheng, Liling Zhuo, Di Ran, et al.
Connective Tissue Research|July 12, 2019
Naringin alleviates H<sub>2</sub>O<sub>2</sub>-induced apoptosis via the PI3K/Akt pathway in rat nucleus pulposus-derived mesenchymal stem cellsLi-Ping Nan, Feng Wang, Di Ran, et al.
Environmental Science & Technology|July 31, 2024
Deciphering the Dual Roles of an Alginate-Based Biodegradable Flocculant in Anaerobic Fermentation of Waste Activated Sludge: Dewaterability and DegradabilityYi-Bo Wang, Jie Tang, Dan-Di Ran, et al.
Journal of Hepatology|April 13, 2025
Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCCLorenza Rimassa, Stephen L Chan, Bruno Sangro, et al.
Hepatology (Baltimore, Md.)|May 19, 2025
Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable hepatocellular carcinoma: HIMALAYA phase 3 randomized clinical trialGeorge Lau, Bruno Sangro, Ann-Lii Cheng, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Antioxidants (Basel, Switzerland)|May 25, 2024
Luteolin Alleviates Cadmium-Induced Kidney Injury by Inhibiting Oxidative DNA Damage and Repairing Autophagic Flux Blockade in ChickensKanglei Zhang, Jiahui Li, Wenxuan Dong, et al.
International Journal of Molecular Sciences|January 23, 2024
Cadmium Induces Kidney Iron Deficiency and Chronic Kidney Injury by Interfering with the Iron Metabolism in RatsKanglei Zhang, Mengfei Long, Wenxuan Dong, et al.
Toxicology|July 22, 2020
TGF-β-activated kinase 1 (TAK1) mediates cadmium-induced autophagy in osteoblasts via the AMPK / mTORC1 / ULK1 pathwayDi Ran, Yonggang Ma, Wei Liu, et al.
Toxicology|October 8, 2020
Cadmium induces apoptosis via generating reactive oxygen species to activate mitochondrial p53 pathway in primary rat osteoblastsJiaming Zheng, Liling Zhuo, Di Ran, et al.
Connective Tissue Research|July 12, 2019
Naringin alleviates H<sub>2</sub>O<sub>2</sub>-induced apoptosis via the PI3K/Akt pathway in rat nucleus pulposus-derived mesenchymal stem cellsLi-Ping Nan, Feng Wang, Di Ran, et al.
Environmental Science & Technology|July 31, 2024
Deciphering the Dual Roles of an Alginate-Based Biodegradable Flocculant in Anaerobic Fermentation of Waste Activated Sludge: Dewaterability and DegradabilityYi-Bo Wang, Jie Tang, Dan-Di Ran, et al.
Journal of Hepatology|April 13, 2025
Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCCLorenza Rimassa, Stephen L Chan, Bruno Sangro, et al.
Hepatology (Baltimore, Md.)|May 19, 2025
Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable hepatocellular carcinoma: HIMALAYA phase 3 randomized clinical trialGeorge Lau, Bruno Sangro, Ann-Lii Cheng, et al.
Pageof 5